WEDNESDAY, Jan. 12, 2022 (HealthDay News) — Wildfires and rising temperatures are exposing more and more Americans to an air pollution double-whammy of smoke and smog, a new study warns. Researchers found that over the past 20 years, a growing number of people in western states have been simultaneously exposedContinue Reading
WEDNESDAY, Jan. 12, 2022 (HealthDay News) — A new report offers hope on the lung cancer front: Patients are being diagnosed at an earlier stage in their disease and living longer due to better access to care, higher screening rates and improved treatments. And that is driving overall cancer ratesContinue Reading
WEDNESDAY, Jan. 12, 2022 (HealthDay News) — The chance of someone who is covered by Medicaid surviving cancer may depend in part on where they live, a new analysis finds. In states that had lower Medicaid income eligibility limits, cancer survival rates were worse for cancers both in early andContinue Reading
TUESDAY, Jan. 11, 2022 (HealthDay News) — It’s a move that could severely limit the number of people taking the controversial new Alzheimer’s drug Aduhelm: Medicare on Tuesday proposed to only cover the cost of the pricey medication for people enrolled in approved clinical trials. A final decision on coverageContinue Reading
TUESDAY, Jan. 11, 2022 (HealthDay News) — For several years, a leading U.S. pediatricians’ group has called for middle and high schools to start later in the morning, to help these young people get the right amount of sleep. Now, new research suggests that students aren’t the only ones whoContinue Reading
TUESDAY, Jan. 11, 2022 (HealthDay News) — Secondhand vapor from electronic cigarettes is harmful to others, causing bronchitis symptoms and shortness of breath in young bystanders, a new study reports. Secondhand exposure to vapor increased teens’ risk of bronchitis symptoms by 40% and shortness of breath by 53%, according toContinue Reading
TUESDAY, Jan. 11, 2022 (HealthDay News) — Parents, brace yourselves. As the Omicron variant surges and U.S. schools deal with a substitute teacher shortage and related pandemic fallout, don’t be surprised if a return to remote or hybrid learning leads your kids to act out, a new study warns. PreviousContinue Reading
TUESDAY, Jan. 11, 2022 (HealthDay News) — Swapping out the butter or other artery-clogging fats in your diet for heart-healthy olive oil may add years to your life, researchers say. Folks who consume more than 1/2 a tablespoon of olive oil a day are less likely to die from heartContinue Reading
TUESDAY, Jan. 11, 2022 (HealthDay News) — Beating cancer is a huge feat, but how survivors live their lives afterwards also influences their longevity. A new study shows those who sit too much and are not physically active are much more likely to die early from cancer or any otherContinue Reading
TUESDAY, Jan. 11, 2022 – (HealthDay News) — Men who are broken-hearted or just unlucky in love could be more likely to have health-damaging inflammation, new research suggests. Serious breakups and solo living for many years may increase the risk of ill health and death — but apparently only forContinue Reading
TUESDAY, Jan. 11, 2022 (HealthDay News) — Examining a woman’s health in midlife can predict her health decades later, researchers say. Four specific factors — higher body mass index (BMI), smoking, arthritis and depressive symptoms — at age 55 are associated with clinically important declines in physical health 10 yearsContinue Reading
TUESDAY, Jan. 11, 2022 (HealthDay News) — If you think frequent changes in weather are triggering your allergy symptoms, you may be right. A shift from a cold front to a rainy day then back to warm weather can have an impact on those with allergies, said Dr. David Corry,Continue Reading
MONDAY, Jan. 10, 2022 (HealthDay News) — Exercise helps you stay fit, hale and hearty, and researchers say it may also help you stave off dementia and Alzheimer’s disease. Now they have a better understanding of the hidden benefits that aid the brain. Older folks who are more physically activeContinue Reading
MONDAY, Jan. 10, 2022 (HealthDay News) — For people newly diagnosed with advanced melanoma, a combination of two immunotherapy drugs can double the amount of time their cancer remains progression-free, a clinical trial has found. The treatment combines two drugs known as immune checkpoint inhibitors. One, called nivolumab (Opdivo), isContinue Reading